|
GABRD
Gamma-aminobutyric acid receptor subunit delta is a protein that in humans is encoded by the GABRD gene.[5][6][7] In the mammalian brain, the delta (δ) subunit forms specific GABAA receptor subtypes by co-assembly leading to δ subunit containing GABAA receptors (δ-GABAA receptors).[8] FunctionThe delta (δ) subunit, one of the subunits of the hetero-pentameric δ-GABAA receptors, is a determinant subunit for the specific cellular localization of δ-GABAA receptors,[8][9] which are modulated by the GABA. GABA is the major inhibitory neurotransmitter in the mammalian brain where it acts on the repertoire of GABAA receptors, the ligand-gated chloride channels. It is assembled from a diverse subunit pool, including assemblies from a family of 19 subunits (α1-α6, β1-β3, γ1-γ3, δ, ∈, θ, π and ρ1-ρ3).[10][9] The GABRD gene encodes the delta (δ) subunit.[7] Specifically, the δ-subunit is usually expressed in GABAA receptors associated with extrasynaptic activity, mediating tonic inhibition, which is slower compared to classical inhibition (phasic or synaptic inhibition).[9] The most common GABAA receptors have the gamma subunit, which allows the receptor to bind benzodiazepines. For this reason, receptors containing δ-subunits (δ-GABAA receptor) are sometimes referred to as “benzodiazepine-insensitive” GABAA receptors. However, they do show an exquisitely high sensitivity to ethanol compared to the benzodiazepine-sensitive receptors, which do not respond to ethanol however these results are not fully confirmed in the literature.[8] The δ-subunit containing receptors are also known to be involved in the ventral tegmental area (VTA) pathway in the brain's hippocampus, which means that they may have implications in learning, memory, and reward.[11] Clinical significanceNeurological and psychiatric disordersMutations or dysregulation of GABRD and other GABA-A receptor subunits have been implicated in conditions such as epilepsy, anxiety disorders, and certain neurodevelopmental disorders.[12][13] Research has suggested that alterations in the GABRD gene may be linked to certain neurological and psychiatric disorders, including anxiety. Anxiety disorders are a group of mental health conditions characterized by excessive and persistent worry, fear, or nervousness. The GABA system, including the GABRD gene, is implicated in the regulation of anxiety and stress responses. While there is ongoing research to understand the complex genetic and neurobiological factors contributing to anxiety disorders, it's important to note that anxiety is a multifaceted condition influenced by a combination of genetic, environmental, and psychological factors. Many genes, neurotransmitters, and brain regions are likely involved in the development and manifestation of anxiety. Individuals with variations in the GABRD gene may exhibit differences in GABA-A receptor function, which could potentially influence their susceptibility to anxiety or other related conditions. However, the interplay of genetics with environmental factors is complex, and it's crucial to consider a holistic perspective when understanding the causes of anxiety.[14] Epilepsy is a neurological disorder characterized by recurrent, unprovoked seizures. GABAergic neurotransmission, mediated by the GABA-A receptor, is essential for maintaining the balance between excitatory and inhibitory signals in the brain. Changes in the functioning of GABA receptors, including those associated with the GABRD gene, can influence this balance and potentially contribute to the development of epilepsy. Research has suggested that alterations in the GABRD gene may be implicated in certain forms of epilepsy. Mutations or variations in genes encoding GABA receptor subunits can affect the function of these receptors, leading to an imbalance in excitatory and inhibitory neurotransmission, which may contribute to the hyperexcitability observed in epilepsy. It's important to note that epilepsy is a complex disorder with various genetic and environmental factors contributing to its development. While some individuals with epilepsy may have genetic mutations affecting GABA receptors, not all cases are directly linked to specific genes.[15] GABA levels, known as the neurotransmitter, one of the most important signals of the mammalian brain, have recently been involved in mood disorders. Genetic studies have also shown that some genes are involved in mood disorders. GABARD is one of the strong candidates among these genes. As a result of studies, it has been proven that the 8 subunits encoded by GABRD are linked to major depressive disorders.[16] CancerGABRD effect has also been observed in some types of cancer. For example, GABRD effect has been observed in colorectal cancer. According to research conducted by scientists, it has been observed that colorectal cancers metastasize.[17] In some neurological diseases, some mutations occur depending on GABRD gene expression, and as a result of these mutations, some diseases occur, for example, epilepsy. Epilepsy is called the sudden discharge process that occurs in the brain, and as a result, sudden contractions occur in the body. but the role of GABRD in epilepsy is less. It has also been observed that it has an effect on autism spectrum disorder as a result of the variation of the GABRD protein.[18] The GABRD gene encodes the δ subunit of the GABA A receptor, which is highly expressed in the brain and mediates tonic inhibition-related signaling. It has also been proven that excessive release of neurotransmitters plays a role in triggering some types of cancer and uncontrolled cell proliferation. In recent studies, GABRD gene expression is at very high levels in colon adenocarcinoma. In addition, scientists have proven in their research that Gabrd expression is excessive in the relevant tissues.[19] Tissue distributionThe cellular localization of mRNAs of 13 GABAA receptor subunits was analyzed in different brain regions.[20] For example, in the cerebellum, various receptor subtypes are found in cerebellar granule cells and Purkinje cells, whereas in the olfactory bulb, periglomerular cells, tufted cells, and internal granule cells express GABAA receptor subtypes.[21] Specifically, the pattern of cell type-specific δ subunit expression is shown in the table below.
In a technical comparison between quantitative reverse transcriptase PCR and digital PCR, the expression of the rat gabrd gene was examined across three cell types in the somatosensory cortex: neurogliaform cells, fast spiking basket cells and pyramidal cells.[22] Gene expression was detected in all three cell types, but showed marked enrichment in neurogliaform cells versus the other cell types examined.[22] The GABAA receptor delta subunit is profoundly downregulated with chronic intermittent exposure to ethanol, and appears to contribute strongly to pathological alcohol dependence.[23] The GABRD gene, encoding the delta subunit of the GABAA receptor, exhibits cell type-specific expression patterns. Primarily found in neurons, particularly in brain regions like the hippocampus and cerebral cortex, GABRD plays a crucial role in inhibitory neurotransmission. Its expression dynamically changes during development, influencing synaptic maturation. Emerging evidence suggests GABRD expression in certain glial cells, indicating potential roles in glia-neuron communication. Additionally, GABRD is detected in peripheral tissues, hinting at non-neuronal functions. Altered GABRD expression is linked to neurological disorders, emphasizing its significance.[24] CloningGABAA receptors were initially cloned by the classical method that the peptide sequences obtained from purified (bovine brain) receptors were used to construct synthetic DNA probes to screen brain cDNA libraries.[9][25][26] Eventually, this technique have led to the identification of most of the gene family with its isoforms: α1-α6, β1-β3, γ1-γ3 subunits and one δ subunit.[27] GFP taggingSubunits of GABA A receptors were tagged by Green Fluorescent Protein (GFP) or its variants (EGFP) to study trafficking, localization, oligomerization, and protein interactions of relevant receptor subtypes and the relevant subunits. Typically, the EGFP or GFP tagging has been done in the N-terminus or C-terminus of the mature peptide sequence of relevant subunit. The GFP tagging of δ-subunit was performed in the different domains of the subunit such as the N-terminus, C-terminus as well as intracellular (cytoplasmic) domain.[28][29][30] Nevertheless, despite these and other studies, it is not clear if this subunit requires α and β subunits for the membrane targeting since literature suggests conflicting results. By the use of GFP tagging of this subunit, one group reported that the cell membrane expression of the δ subunit was observed only in the presence of both α and β subunits.[30] However, another group suggested that the δ subunit can target to the cell membrane and the βδ containing receptors exist.[31] See alsoReferences
Further reading
External links
This article incorporates text from the United States National Library of Medicine, which is in the public domain. |
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
